What Will Vaccine Liability Waivers Mean For The Covid-19 Inoculation

What Will Vaccine Liability Waivers Mean For The Covid-19 Inoculation. There will be issues with the new Coronavirus/Covid-19 vaccine because there were issues with every single vaccine introduced before. There are currently numerous studies and trials devoted to finding a shot that will give immunity to the recipient against the deadly and contagious Coronavirus/Covid-19 pandemic. The company that is first to introduce a successful shot for immunity will reap big rewards in the form of profits and scientific prestige. But when there are problems with it, as there certainly will be, what recourse does the public have?

Vaccine Liability Photo
Vaccine waivers protect manufacturers from lawsuits and liability other drugs have.

On his regular podcast, respected neurologist Dr. Steven Goldstein describes the risks and benefits of vaccines and a regulation known as the ‘vaccine liability waiver.’ The Houston Healthcare Initiative Podcast can be heard on SoundCloud, LibSyn, Google Play, iHeartRadio, iTunes, Stitcher, Radio.com and many other places where podcasts are heard.

What Is The Vaccine Liability Waiver?

According to Dr. Goldstein, vaccine liability waivers are really what the name implies which is that vaccine makers are not generally held responsible for injuries their vaccines may cause. “This is notable because it is the only part of the healthcare industry where such protection exists,” Dr. Goldstein told his listeners. “The companies that make these vaccines cannot be sued for monetary damages unless a person who died or was seriously injured can demonstrate that the company engaged in “willful misconduct” which is a very high legal standard to achieve.”

The Vaccine Waiver Makes Vaccines Possible

What Will Vaccine Liability Waivers Mean For The Covid-19 Inoculation? It is very likely that were it not for the ‘waiver’ there would be few if any vaccine makers in the U.S. Starting with the Salk vaccine in the 1950’s through the 1970’s and ‘80’s, lawsuits against vaccine makers increased to the point that there was only one Diphtheria Pertussis Tetanus (DPT) vaccine maker in the U.S.

In 1986 the U.S. Congress responded to the situation in the vaccine market by passing the ‘National Childhood Vaccine Injury Act’ or NCVIA. The act included a number of regulations related to informed consent and adverse event reporting but also removed many of the monetary recovery options that were putting the industry out of business.

Complexity Comes With Safeguards

Vaccines are developed, tested, and regulated the same as other drugs but more so. Vaccine development is a complex process that takes usually takes years. That is because the number of people in vaccine clinical trials are usually greater, and, those who receive vaccines are more in number than those who receive or take other prescription drugs. In addition, post-license monitoring of vaccines is closely examined by the Centers for Disease Control (CDC) and the Food & Drug Administration (FDA).

So, while the liability waiver exists, all the other pharmaceutical safeguards are in place. Regardless of expectations, no medical treatment is completely risk free. “Vaccines are made to protect us from disease, but they can have negative side effects,” Dr. Goldstein said. “Most of these effects are pretty mild like soreness in the arm from the injection. Others can be more serious. But without these rules it is unlikely anyone in the U.S. would be researching a Covid-19 vaccine.”

What Will Vaccine Liability Waivers Mean For The Covid-19 Inoculation? Nothing in the world of medicine is without risk and the ultimate introduction of the Coronavirus vaccine is no exception. The laws and regulations strike a balance that protects the public and aids in the delivery of a vaccine sooner than later.

The Effectiveness Standard for Covid-19

The minimum requirement by the Food and Drug Administration (FDA) for any COVID-19 vaccine is that it should at least prove 50% effective when compared with a placebo — that is, a neutral saline solution. The annual flu vaccine is a success when it is 40% – 60% effective. Fifty percent is right in the same range as the flu vaccine.

About The Houston Healthcare Initiative

Dr. Steven Goldstein is a Houston based neurologist. He founded the Houston Healthcare Initiative and is an advocate for common sense solutions to the healthcare crisis that confronts the citizens and residents of the United States of America.

 

Vaccine Development Liability Waivers Where Safety & Business Gel

The pluses and minuses of the vaccine liability waver laws on this edition of the Houston Healthcare Initiative Podcast.

Vaccine Development Liability Waivers Where Safety & Business Gel.

There are currently 120 Coronavirus/Covid-19 vaccines in development and a race to be the first one available for the public. Being first with this vaccine will mean big rewards for the maker in the form of profits and scientific prestige. Along with these developments there is political pressure to not only be first but be first by election day.

Regardless, the benefits of a vaccine for this extremely contagious virus will ultimately accrue to the public. But nothing is foolproof and there will be problems with this vaccine because there were with all of them. And when there are problems who is ultimately responsible and how can the public find justice? To know better what the possible risk benefit for a vaccine to the Covid-19 is and help us understand the possible downside and upside is respected Houston neurologist Dr. Steven Goldstein. On his podcast Dr. Goldstein describes the advantages of vaccine liability waivers and the potential downside.

Off Label Prescriptions Removed From The Table Overly Zealous Watchdogs Interfere with Patients and their Doctors

Off Label Prescriptions Removed From The Table….

Overly Zealous Watchdogs Interfere with Patients and their Doctors

October 1, 2020 – Does a physician or the pharmacist know what is best for a patient? When the Ohio

Off Label Prescriptions Removed From The Table….  Overly Zealous Watchdogs Interfere with Patients and their Doctors   October 1, 2020 – Does a physician or the pharmacist know what is best for a patient? When the Ohio Board of Pharmacy ruled that doctors could not prescribe the off-label treatment hydroxychloroquine to treat the Coronavirus/Covid-19 pandemic it was a chilling trespass into the rights of people in Ohio and set a dangerous precedent in the other forty nine.  Medicines to treat conditions with off-label prescribing occurs when a physician stipulates a drug that the U.S. Food and Drug Administration (FDA) has approved to treat a condition different than what a patient has. Off label prescribing is nothing new.   Unanticipated Consequences of Overly Aggressive Regulators This practice is legal and common as one in five prescriptions written today are for off-label use. The Ohio Board of Pharmacy decision was without precedent. Americans should be nervous about this instance because it puts the relationships between doctors and patients at risk and removes the judgement of physicians about how to best treat their patients, putting it into the hands of government regulators. “This overreach is a present and future danger for Americans and their doctors in the wake of the Coronavirus/Covid-19 pandemic,” Dr. Steven Goldstein told the audience on his podcast. “This puts decision making about how best to treat a patient into the hands of someone who does not know the individual, never mind has any medical experience with them.”  The Future Beyond Covid-19 The prospect that someone other than the doctor and patient are involved in this decision making is bad practice. “Doctors are trained and educated to diagnose and treat patients”, Dr. Goldstein said. “They also have experience treating their patients and know how to evaluate scientific papers about new treatments. Pharmacists and government bureaucrats do not have this training or experience.”   In the case of hydroxychloroquine there is no randomized controlled trial to prove scientifically whether or not this drug is effective for Covid-19. It is also true that there is no other treatment that has been proven with a randomized controlled trial to be effective. “Physicians should be able to use any treatment that may be beneficial to their patient,” Dr. Goldstein said. “Interference by government boards or other non-physicians will retard the development of effective treatments and lead to additional mortality and morbidity.” The next outbreak is a certainty, it’s only a matter of time. “If pharmacists and bureaucrats are getting between doctors and patients now, we should be very worried about the future,” Dr. Goldstein concluded.  About the Houston Healthcare Initiative Podcast The Houston Healthcare Initiative podcast with Dr. Steven Goldstein is an information vehicle for people who want to know all medical options for themselves and are interested in reforming the healthcare industry. To hear the podcast go to: SoundCloud, iHeartRadio, Stitcher, Backtracks, LibSyn, or the website at www.houstonhealthcareinitiative.org. Dr. Goldstein insists that for the health and welfare of the American public, the congress must pass reforms that limit the influence of the pharmaceutical industry and its lobby.
Overly Zealous Watchdogs Interfere with Patients and their Doctors.

Board of Pharmacy ruled that doctors could not prescribe the off-label treatment hydroxychloroquine to treat the Coronavirus/Covid-19 pandemic it was a chilling trespass into the rights of people in Ohio and set a dangerous precedent in the other forty nine.  Medicines to treat conditions with off-label prescribing occurs when a physician stipulates a drug that the U.S. Food and Drug Administration (FDA) has approved to treat a condition different than what a patient has. Off label prescribing is nothing new

Unanticipated Consequences of Overly Aggressive Regulators

This practice is legal and common as one in five prescriptions written today are for off-label use. The Ohio Board of Pharmacy decision was without precedent. Americans should be nervous about this instance because it puts the relationships between doctors and patients at risk and removes the judgement of physicians about how to best treat their patients, putting it into the hands of government regulators. “This overreach is a present and future danger for Americans and their doctors in the wake of the Coronavirus/Covid-19 pandemic,” Dr. Steven Goldstein told the audience on his podcast. “This puts decision making about how best to treat a patient into the hands of someone who does not know the individual, never mind has any medical experience with them.”

The Future Beyond Covid-19

The prospect that someone other than the doctor and patient are involved in this decision making is bad practice. “Doctors are trained and educated to diagnose and treat patients”, Dr. Goldstein said. “They also have experience treating their patients and know how to evaluate scientific papers about new treatments. Pharmacists and government bureaucrats do not have this training or experience.

In the case of hydroxychloroquine there is no randomized controlled trial to prove scientifically whether or not this drug is effective for Covid-19. It is also true that there is no other treatment that has been proven with a randomized controlled trial to be effective. “Physicians should be able to use any treatment that may be beneficial to their patient,” Dr. Goldstein said. “Interference by government boards or other non-physicians will retard the development of effective treatments and lead to additional mortality and morbidity.” The next outbreak is a certainty, it’s only a matter of time. “If pharmacists and bureaucrats are getting between doctors and patients now, we should be very worried about the future,” Dr. Goldstein concluded.

About the Houston Healthcare Initiative Podcast

The Houston Healthcare Initiative podcast with Dr. Steven Goldstein is an information vehicle for people who want to know all medical options for themselves and are interested in reforming the healthcare industry. To hear the podcast go to: SoundCloud, iHeartRadio, Stitcher, Backtracks, LibSyn, or the website at www.houstonhealthcareinitiative.org. Dr. Goldstein insists that for the health and welfare of the American public, the congress must pass reforms that limit the influence of the pharmaceutical industry and its lobby.

 

 

Federal Government Goofs Delayed Coronavirus Tests By 6-8 Weeks

The United States badly bungled coronavirus testing.
The United States badly bungled initial coronavirus testing. Federal Government Goofs Delayed Coronavirus Tests By 6-8 Weeks.

Federal Government Goofs Delayed Coronavirus Tests By 6-8 Weeks. On his regular podcast Dr. Steven Goldstein described how failures within the federal government delayed proper testing for the Coronavirus/Covid-19 virus by several weeks.  The outcome? Tracking and tracing the infection early in the process was impossible. The Houston Healthcare Initiative Podcast is available on SoundCloud, iHeartRadio,LibSyn, Spotify,  iTunes, Radio.com, Stitcher, ListenNotes, Podcast Addict, or the Houston Healthcare Initiative web site.

Early Kit Troubles

Early in the testing process the Food and Drug Administration (FDA) sent Coronavirus/Covid-19 test kits to approximately 100 health labs across the country. Initially the FDA had done all the testing in in-house, but more cases meant that tests had to be available in more locations. There was just one, very important mistake and that was there was no way to validate the tests and its ingredients all acted the same way when used, regardless of the location.

Thirty-six of the approximately 50 tests returned results to the FDA that were ‘inconclusive’. Manufacture of new ingredients for the tests took 3 weeks. The failure to get working test kits into public-health labs came at a really bad time. Early in any outbreak, contact tracing, isolation, and individual quarantines are used to contain the spread of disease. These steps don’t work when suspected cases cannot be tested. The gap made by the bad test kits made it impossible for public-health officials to get a read on how far and fast the disease was spreading. The result, Covid-19 spread undetected for several weeks. “The government was not prepared when it came to identifying and quarantining contacts of the first patients and preventing sick patients from entering the country,” Dr. Goldstein told his listeners. “Government bureaucracy delayed the development of laboratory tests for 6-8 weeks.”

Worse still, when an Emergency Use Application (EUA) test was sent via email and followed up with phone calls from the University of Washington Virology Lab to the FDA for approval, the applicants learned that U.S. law required a hard copy of the applications be sent with a CD or thumb drive via the U.S. Postal Service to be considered. Instead of using more advanced communications like e-mail the lab was forced to use ‘snail mail’. (The F.D.A. has since dropped the requirement to send a CD-rom or USB drive with a copy of the application).

Bureaucrats Want More Power Not Less

According to Dr. Goldstein, issues like this have more to do with the bureaucratic class maintaining its influence than protecting the public or any devotion to science. “People ensconced in government bureaucracy want to preserve their authority and it seems that they are willing to take drastic measures to preserve that power,” Dr. Goldstein said. “These people are very invested in expensive, high tech treatments. Low tech measures like contact tracing and quarantining and testing anyone entering the country could have controlled the epidemic early on.” One possible lesson from this is to remember that government takeover of any health crisis will persist long past any benefit is exhausted. Finding ways around these career government employees should be part of any proposed reform for the healthcare industry.

About the Houston Healthcare Initiative

Dr. Steven Goldstein is a Houston based neurologist. He founded the Houston Healthcare Initiative and is an advocate for common sense solutions to the healthcare crisis that confronts the citizens and residents of the United States of America. Federal Government Goofs Delayed Coronavirus Tests By 6-8 Weeks.

 

Possible Remedy for the Coronavirus/Covid-19 Global Pandemic Invites Immediate Controversy

Blood Plasma
Possible Remedy for the Coronavirus/Covid-19 Global Pandemic Invites Immediate Controversy
Treatment with blood plasma from recovered patients is an accepted practice that goes back to the early 20th century.

Possible Remedy for the Coronavirus/Covid-19 Global Pandemic Invites Immediate Controversy.

On August 23, 2020 the Food and Drug Administration (FDA) announced a decision to grant blood plasma treatment for Coronavirus/Covid-19 patients with a fast-track authorization for its emergency use as a treatment for hospitalized COVID-19 patients.

The next day, claims about the effectiveness of this treatment were retracted. Subsequent news coverage about this potential treatment did little to clarify blood plasmas’ usefulness or lack thereof. The idea that there could be a political motivation behind the fast track authorization for this potential treatment, other than looking for a useful therapeutic, is troubling.

Who Can Americans Believe?

On his regular ‘Houston Healthcare Initiative’ podcast, respected neurologist Dr. Steven Goldstein defines how this decision triggered an outcry from scientists and doctors, who said the decision was not supported by adequate clinical evidence and criticized the FDA for what was perceived as bowing to ‘political pressure’.

Dr. Goldstein also reviews those who believed this approach was worthwhile. Generally, treatment with blood plasma from recovered patients is an accepted practice that goes back to the early 20th century. Many believe the possibility that blood plasma from recovered Coronavirus/Covid-19 patients could help people fight off the virus was worthy of further investigation.

Who is correct? Who should the American public rely on for the best information about treatment for this global health emergency?

The Houston Healthcare Initiative podcast can be heard on: SoundCloud, Apple Podcasts, Stitcher, Listen Notes, iHeartRadio, and the Houston Healthcare Initiative web site.

About Houston Healthcare Initiative And Dr. Steven Goldstein

Dr. Steven Goldstein is a Houston based neurologist. He founded the Houston Healthcare Initiative and is an advocate for common sense solutions to the healthcare crisis that confronts the citizens and residents of the United States of America. Blood plasma treatment for Covid-19 patients invites controversy.

Blood Plasma Covid Treatment and Pharmaceutical Industry Reform

Blood plasma covid treatment and pharmaceutical industry reform. On August 23, 2020 the Food and Drug Administration’s announced a decision to grant blood plasma treatment for Coronavirus/Covid-19 patients with a  fast-track authorization for its emergency use as a treatment for hospitalized COVID patients. This “emergency use authorization” triggered an outcry from scientists and doctors, who said the decision was not supported by adequate clinical evidence and criticized the FDA for what was perceived as bowing to political pressure.

Should Pharma choose people over profit?
Big Pharma has a big influence on the congress from multi-million dollar lobbying effort.

News coverage about this potential treatment has done little to clarify whether its useful or not. The idea that there could be a motivation behind the fast track authorization for this potential treatment other than looking for a useful therapeutic is troubling. More to the point, who should decide what patients receive in treatment for their illnesses? To help us make sense of how reforms for the pharmaceutical industry could potentially help separate facts from spin and who we should all listen to is respected neurologist, Dr. Steven Goldstein. Click below to listen.

To read more about this issue please click below: https://www.sciencemag.org/news/2020/08/fda-s-green-light-treating-covid-19-plasma-critics-see-thin-evidence-and-politics.

The Source of the Misunderstanding: Retracted Article Mischaracterizes Hydroxychloroquine

Like un-ringing a bell.

Retracted Article Mischaracterizes Hydroxychloroquine. No one can un-ring a bell. No article can be ‘un-read’ or any eventual retraction definitely seen and understood. There are few more illustrative examples lately than when respected medical journals published information about the use of Hydroxychloroquine as a possible treatment for the Coronavirus/Covid-19 virus they later retracted.

HCN
Large French Real World Observational Study Reveals Hydroxychloroquine Azithromycin-Associated with Reduction in Hospitalization-Death for COVID 19 Patients.

On his podcast, respected, Houston based neurologist Dr. Steven Goldstein describes how the well-established, inexpensive drug Hydroxychloroquine was mischaracterized. To listen to the podcast please visit: SoundCloud, Libsyn,iHeart, and the Houston Healthcare Initiative web site.

Article Retracted But Damage Done

Early in the pandemic, Hydroxychloroquine looked like it could be a possible treatment for Coronavirus/Covid-19 ,but use of and studies about the drug quickly lost favor after articles in the Lancet and New England Journal of Medicinecast doubt. The later retracted study and reporting about it had an immediate impact. The World Health Organization (WHO) stopped their research into hydroxychloroquine. Multiple news web sites carried the message that Hydroxychloroquine was not effective, citing the New England Journal of Medicine as its source. One example was from the NBC News web site read, “Hydroxychloroquine fails to prevent COVID-19, large study finds.”

Damage Done

While the articles were retracted the information originally published, could not be ‘unseen.’ “The news media touted these articles, that falsely claimed there was no evidence that treatment with Hydroxychloroquine was effective,” Dr. Goldstein told his listeners.  “A French study published March 20, 2020 suggested the drug helped people with coronavirus, reporting it “is significantly associated with viral load reduction/disappearance in patients with COVID-19.”

The article and its author, French physician and scientist, Dr. Didier Raoult, who authored papers showing favorable results, were personally and professionally attacked (The New York Times) among others. Suffice to say that way more people saw and continue to see these refuted articles, even though they were retracted. But the harm from them remains.

About The Houston Healthcare Initiative

Houston Healthcare Initiative is a group of physicians and health conscious patients that have joined together in a Healthcare cooperative to maintain and improve the physical and mental health of each member of the group. Visit online at https://houstonhealthcareinitiative.org.

Sources and Links

“Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.” N Engl J Med. DOI: 10.1056/NEJMoa2007621. https://www.nejm.org/doi/full/10.1056/NEJMc2021225.

June 25, 2020 N Engl J Med 2020; 382:2582. DOI: 10.1056/NEJMc2021225

“Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.” Published: June 05, 2020.

By: Mandeep R Mehra,   Frank RuschitzkaAmit N Patel.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31324-6/fulltext

“Two elite medical journals retract coronavirus papers over data integrity questions”

By: Charles PillerKelly Servick Jun. 4, 2020 , 5:30 PM

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31324-6/fulltext

“He Was a Science Star. Then He Promoted a Questionable Cure for Covid-19.” The New York Times By Scott Sayare. Published May 12, 2020 Updated May 21, 2020

“French Doctor Leads Charge for Treating Coronavirus With Antimalarial Drug”

Health authorities say evidence is inconclusive that the treatment, which President Trump has backed, is effective. By Nick Kostov and David Gauthier-Villars

Updated April 11, 2020 7:52 pm ET

https://www.wsj.com/articles/french-doctor-leads-charge-for-treating-coronavirus-with-antimalarial-drug-11586629801

Retracted Article Mischaracterizes Hydroxychloroquine.

Retracted Article Mischaracterizes Hydroxychloroquine.

Was There Ever A Better Time To Reform Drug Prices?

US & Canadian Drug Prices

In the Coronavirus/Covid-19 Pandemic Age Come Ideas for Drug Price Reform

In the coronavirus/covid-19 pandemic age drug reform is topical.

According to Dr. Steven Goldstein on his podcast, “without meaningful modification, drug prices and pressure on patient’s ability to pay and manufacturers resources for discovery will reach a tipping point.” Dr. Steven Goldstein lists the reasons for the discrepancy and how the U.S. could reform the laws that govern the ways therapeutic medicine gets from the lab bench all the way to the patient for whom it is intended.

Some of these include:

  • Reform drug patent law. The patent system for drugs needs to be reformed so that drug development costs can be recouped along with a profit. Once this occurs, the patent should expire.
  • Streamline approval. The FDA needs reform so that drug authorizations are more efficient. Possibly, an international FDA funded by a consortium of countries could approve drugs.
  • Eliminate monetary incentives from drug companies for writing prescriptions.
  • Drug discounts to insurance companies and Medicare should be illegal.
  • Enforce the laws already passed. Antitrust laws for price collusion need to be enforced.

    US & Canadian Drug Prices
    In the coronavirus/covid-19 pandemic age drug reform is topical. For U.S. drug prices to be affordable and provide enough resources for continued research serious reform is needed. 

To hear Dr. Goldstein’s podcast listen on SoundCloud, iHeartRadio, iTunes, Stitcher, and the website at www.houstonhealthcareinitiative.org.

 

For Those Who Lost Their Employer Funded Health Insurance; Resources Are Available

Provided at no charge by the Houston Healthcare Initiative.  

For Those Who Lost Their Employer Funded Health Insurance Resources Are Available

Because of the Coronavirus/Covid-19 pandemic, 25–43 million people could lose their jobs and their health insurance. People who had a serious illness before the outbreak and job loss could be dealt a literally fatal blow. Others who had symptoms and even serious accidents while unemployed and without insurance could suffer more than they would have if their insurance were in place. But there are resources available as described this week on the Houston Healthcare Initiative podcast. To learn more, go to www.houstonhealthcareinitiative.org. To hear about this on Dr. Goldstein’s podcast, please visit: Job Losses Equal Employer Funded Health Insurance Loss.

  • Testing for the Coronavirus/Covid-19 illness: testing for the Coronavirus/Covid-19 virus is free. But if the test is positive and you have the virus, the treatment for it can get expensive. Fortunately, most people recover at home. However, an estimated 15% of infected people may end up hospitalized, according to the Kaiser Family Foundation. Recent data suggests that patients who go to intensive care stay there for an average of 20 days. The Castlight Covid-19 test site finder will provide information on Coronavirus testing near you: https://my.castlighthealth.com/corona-virus-testing-sites/.
  • The Health Insurance Exchange: Open enrollment typically runs from November to January, depending on the state in which you live. But people are allowed a change in coverage when experiencing a life altering event. One such event is the loss of a job and employer sponsored health insurance. You can shop for health plans through your state’s insurance marketplace. But don’t wait around, there are 30 to 60 days to sign up after a qualifying life event before the end of that special enrollment period. Go to this link and find out if you qualify for coverage: https://www.healthcare.gov.
  • Medicaid: Medicaid provides health coverage for some low-income people, families and children, pregnant women, the elderly, and people with disabilities in all fifty states.  In some states the program covers all low-income adults below a certain income level. But do not assume that you do or do not qualify. There are online resources available from the U.S. Department of Health and Human Services along with state references to guide you. Visit the official U.S. government Medicaid site to see of you are eligible: https://www.medicaid.gov.
  • CHIP: CHIP stands for Children’s Health Insurance Program. If your children need health coverage, they may be eligible for the Children’s Health Insurance Program (CHIP). CHIP provides low-cost health coverage to children in families that earn too much money to qualify for Medicaid. In some states, CHIP covers pregnant women. Each state offers CHIP coverage and works closely with its state Medicaid program. Get all the details, go to: https://www.healthcare.gov/medicaid-chip/childrens-health-insurance-program/.
  • Faith Based Cooperatives: Faith-based plans are designed to provide essential coverage for the good health and physical well-being of their members. In return they expect members to live faith-based lives in adherence to the principles behind such plans. As such, faith-based plans will not cover hospital costs that stem from activities they deem immoral or unessential. Faith based plans most often share expenses among members. Each member pays a monthly premium. When one of the members becomes ill or needs treatment for an injury, his or her contributions cover the expenses, in conjunction with the collective input of fellow members. As such, the premiums are lower in comparison to those of traditional health care. These operate with exemptions to the mandates of the Affordable Care Act, also known as Obama Care. There are several options. Here are a few:Medi-Share, Liberty HealthShare, Samaritan MinistriesOneShare, Christian Healthcare Ministries.

This is not an exhaustive list for those who lost their employer funded health insurance but is some go the most popular ones that are available.

About Houston Healthcare Initiative And Dr. Steven Goldstein

Dr. Steven Goldstein is a Houston based neurologist. He founded the Houston Healthcare Initiative and is an advocate for common sense solutions to the healthcare crisis that confronts the citizens and residents of the United States of America.

The Healthcare Not Received During the Coronavirus/Covid-19 Pandemic

From Heart Attacks to Cancer Screenings and Chemotherapy

During the Coronavirus/Covid-19 pandemic, people who did not have symptoms of the disease put themselves at risk as those with chronic conditions missed treatments, skipped appointments and chose not to report serious symptoms; this is the healthcare not received during the coronavirus/covid-19 pandemic. Many who lost their employer funded health insurance also missed schedules and treatments. Add to this the fear of visiting a doctor’s office or clinic with reported cases of Coronavirus/Covid-19 on the uptick, another health crisis may be on the horizon.

This was one of the issues affecting the American public discussed by Houston based neurologist Dr. Steven Goldstein on his regular podcast. The Houston Healthcare Initiative podcast can be heard on: Soundcloud, iHeart, Spotify, or iTunes. To learn more about the Houston Healthcare Initiative, go to www.houstonhealthcareinitiative.org.

Cancer Screenings Plummet

No Visitors
Patients who may need to be seen in the office are choosing not to go to the doctor for lots of reasons.

In March and April, patients were asked to postpone appointments that were not urgent. According to a white paper published by ‘Epic Health Research Network’ cancer screenings for cervix, colon, and breast cancer decreased between 86% – 94% in March, 2020. Care for heart attacks, organ transplants, high blood pressure and diabetes fell in March and remain significantly lower compared to the same time in 2019. “There is a 20% decrease in the number of interactions between patients and their oncologists during the COVID-19 pandemic,” Dr. Goldstein told his listeners. “Anytime a screening is delayed, it means that detection and early treatment are too, plus important therapy on advanced cancer are not administered.

Some Need To Be Seen

Many physicians, like Dr. Goldstein, ramped up their telemedicine capabilities in March and see patients that way. But there are still times when a patient needs to be seen. Instances where patients have symptoms that include shortness of breath is one. This symptom could signal heart failure, asthma, pneumonia or even the Covid-19 virus. A diagnosis like that cannot be done over the phone. “Patients and their families should err on the side of caution, contact their doctor and allow their physician the opportunity to make the right decision for the best treatment,” Dr. Goldstein said.

What Concerned Patients Can Ask

For those who believe or are told they must get in to see a doctor, and there is time available in a non-emergency, Dr. Goldstein has some potential questions to pose.

  • Does everyone on staff and patients wear masks?
  • Are the number of persons allowed in the office limited?
  • Has everyone on staff been tested for COVID-19?
  • Are cleaning protocols sufficient to manage waiting rooms, offices, and labs?
  • Has the patient taken responsibility for social distancing, hand washing and mask wearing themselves?

According to Dr. Goldstein, “we have a responsibility to our patients to provide the most appropriate and effective care possible while at the same time keeping potential exposure to the Coronavirus/Covid-19 virus to a minimum.”

About Houston Healthcare Initiative And Dr. Steven Goldstein

Dr. Steven Goldstein is a Houston based neurologist. He founded the Houston Healthcare Initiative and is an advocate for common sense solutions to the healthcare crisis that confronts the citizens and residents of the United States of America.